Br J Pharmacol. 2010 Jan;159(1):1-4. doi: 10.1111/j.1476-5381.2009.00635.x.
BJP has a new look and is re-launching in this first issue of 2010. We have been listening to what authors and readers want from a pharmacology journal and hope that you will choose to submit your best papers here. Similarly, readers will find the best science on how drugs work in every system and at every level. However, the substantial aspects that should attract you are as follows: Impact Factor for 2008 is a highly competitive 4.902. Wider scope – we cover all aspects of pharmacology, molecules to man; translational and integrative bioscience pharmacology. Free to author colour throughout – print and online. No initial handling charge. No page charges. Open Access policy that meets all funding body requirements. High quality press editing service. PowerPoint downloads of all figures. Downloadable movies and other supporting information files. New Editorial Board and peer-review process. Linked commentaries on exciting or controversial papers. Themed Issues and Sections. Press releases on newsworthy papers. Ensuring the readership for your paper by targeted marketing. This re-launch issue contains a themed section on ‘QT Safety’, dealing with drug-induced toxicities associated with prolongation of the cardiac QT interval (http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2010). Subsequent issues will have themed sections on Imaging in Pharmacology (guest edited by Anthony Davenport and Craig Daly) and GPCRs (guest edited by Roger Summers; following on from the highly successful 2009 GPCR Issue (http://www3.interscience.wiley.com/journal/122575288/issue). Our new, fresh, blue cover design harmonises with our sister journal BJCP's similar green cover, symbolically indicating that our two journals, in the BPS stable, are now working together to cover all of pharmacology. The new design reflects the BPS logo (British Pharmacological Society).
BJP 焕然一新，于 2010 年第一期重新发行。我们一直在倾听作者和读者对药理学杂志的需求，希望您选择在这里提交您的最佳论文。同样，读者将在每个系统和每个层面上找到关于药物作用的最佳科学。然而，吸引您的主要方面如下：2008 年的影响因子为 4.902，极具竞争力。更广泛的范围-涵盖药理学的各个方面，从分子到人类；转化和综合生物科学药理学。免费为作者提供全彩-印刷和在线。无初始处理费。无页码费。符合所有资助机构要求的开放获取政策。高质量的新闻编辑服务。所有图表的 PowerPoint 下载。可下载的电影和其他支持信息文件。新的编辑委员会和同行评审过程。对激动人心或有争议的论文的评论。专题问题和部分。有关有新闻价值的论文的新闻稿。通过有针对性的营销确保您的论文的读者群。本期重新发行的特刊是关于“QT 安全性”的，涉及与心脏 QT 间期延长相关的药物毒性（http://www3.interscience.wiley.com/journal/121548564/issueyear?year=2010）。随后的问题将有关于影像学在药理学中的专题部分（由 Anthony Davenport 和 Craig Daly 编辑）和 GPCRs（由 Roger Summers 编辑；继 2009 年 GPCR 问题（http://www3.interscience.wiley.com/journal/122575288/issue）之后）。我们新的、清新的蓝色封面设计与我们的姊妹期刊 BJCP 的类似绿色封面相协调，象征性地表明我们的两个期刊，在 BPS 的稳定中，现在正在共同努力涵盖所有药理学。新设计反映了 BPS 标志（英国药理学会）。
